Investigation of the Neurovegetative Pattern in Patients With Thoracic Aortic Aneurysms (TAA)
IPaNeMA
1 other identifier
observational
139
1 country
1
Brief Summary
The goal of this observational cross-sectional study is to learn about vagal features in patients with syndromic and non-syndromic TAA. The main question it aims to answer is to highlight a functional condition that could help stratify patients with TAA on the risk of aortic complications. Participant will take part by standing in supine position for 10 minutes and during active standing for 10 minutes. In this period of time, it will be possible to acquire the signals continuously and non invasively through recorded non-invasive blood pressure and piezoelectric sensor breathing belt.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 9, 2021
CompletedFirst Submitted
Initial submission to the registry
January 10, 2023
CompletedFirst Posted
Study publicly available on registry
January 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedSeptember 10, 2025
September 1, 2025
3 years
January 10, 2023
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Supine resting (REST) and active standing (STAND)
Baroreflex sensitivity
18 months
Study Arms (2)
Syndromic TAA
Patients presenting either clinical or genetic phenotype referring to a syndrome related to Thoracic Aortic Aneurysms
Non-syndromic TAA
Patients presenting Thoracic Aortic Aneurysms
Interventions
Analysis of baroreflex sensitivity
Eligibility Criteria
Primary care clinic, hospitals.
You may qualify if:
- Patients aged 18-65 years with syndromic and nonsyndromic TAA;
- Signed informed consent;
- Patients on regular pharmacological prophylaxis (with Losartan) or naïve patients with a first diagnosis
You may not qualify if:
- Acute and chronic inflammatory diseases such as: liver disease, chronic renal insufficiency (creatinine \> 1.5 mg/dl) and diseases affecting the thyroid system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IRCCS Policlinico S. Donatolead
- Politecnico di Milanocollaborator
Study Sites (1)
IRCCS Policlinico San Donato
San Donato Milanese, Lombardy, 20097, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 10, 2023
First Posted
January 30, 2023
Study Start
November 9, 2021
Primary Completion
October 25, 2024
Study Completion
January 1, 2026
Last Updated
September 10, 2025
Record last verified: 2025-09